The Biotech Growth Trust PLC (LSE:BIOG) — Market Cap & Net Worth
Market Cap & Net Worth: The Biotech Growth Trust PLC (BIOG)
The Biotech Growth Trust PLC (LSE:BIOG) has a market capitalization of $4.05 Million (GBX33.28 Billion) as of September 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #29079 globally and #523 in its home market, demonstrating a -1.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying The Biotech Growth Trust PLC's stock price GBX1604.00 by its total outstanding shares 20747975 (20.75 Million). Also see BIOG current and non-current assets for a full breakdown of the balance sheet.
The Biotech Growth Trust PLC Market Cap History: 2015 to 2026
The Biotech Growth Trust PLC's market capitalization history from 2015 to 2026. Data shows growth from $1.87 Million to $4.05 Million (8.64% CAGR). Also see The Biotech Growth Trust PLC cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
The Biotech Growth Trust PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE All-Share
FTAS
|
$64.30 Billion | 0.01% | #373 of 573 |
Weight: The Biotech Growth Trust PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
The Biotech Growth Trust PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how The Biotech Growth Trust PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check The Biotech Growth Trust PLC (BIOG) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
-0.04x
The Biotech Growth Trust PLC's market cap is -0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.78 Million | $-126.69 Million | -$128.95 Million | -0.01x | N/A |
| 2017 | $1.99 Million | $100.47 Million | $98.30 Million | 0.02x | 0.02x |
| 2018 | $1.60 Million | $-27.51 Million | -$29.78 Million | -0.06x | N/A |
| 2019 | $2.37 Million | $23.05 Million | $21.10 Million | 0.10x | 0.11x |
| 2020 | $3.98 Million | $63.89 Million | $60.90 Million | 0.06x | 0.07x |
| 2021 | $3.00 Million | $204.35 Million | $200.43 Million | 0.01x | 0.01x |
| 2022 | $2.34 Million | $-209.71 Million | -$202.42 Million | -0.01x | N/A |
| 2023 | $2.26 Million | $-37.65 Million | -$41.30 Million | -0.06x | N/A |
| 2024 | $2.16 Million | $80.35 Million | $74.60 Million | 0.03x | 0.03x |
| 2025 | $3.03 Million | $-77.48 Million | -$82.66 Million | -0.04x | N/A |
Competitor Companies of BIOG by Market Capitalization
Companies near The Biotech Growth Trust PLC in the global market cap rankings as of September 19, 2026. Review The Biotech Growth Trust PLC tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to The Biotech Growth Trust PLC by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #142 globally with a market cap of $166.07 Billion USD.
- Blackstone Group Inc (NYSE:BX): Ranked #281 globally with a market cap of $94.05 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #299 globally with a market cap of $88.70 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #312 globally with a market cap of $85.27 Billion USD ( CA$117.88 Billion CAD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #142 | BlackRock Inc | NYSE:BLK | $166.07 Billion | $1069.78 |
| #281 | Blackstone Group Inc | NYSE:BX | $94.05 Billion | $124.96 |
| #299 | KKR & Co. Inc. | NYSE:KKR | $88.70 Billion | $98.81 |
| #312 | Brookfield Corporation | TO:BN | $85.27 Billion | CA$52.52 |
The Biotech Growth Trust PLC Historical Marketcap From 2015 to 2026
Between 2015 and today, The Biotech Growth Trust PLC's market cap moved from $1.87 Million to $ 4.05 Million, with a yearly change of 8.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX4.05 Million | +33.67% |
| 2025 | GBX3.03 Million | +40.35% |
| 2024 | GBX2.16 Million | -4.36% |
| 2023 | GBX2.26 Million | -3.46% |
| 2022 | GBX2.34 Million | -22.05% |
| 2021 | GBX3.00 Million | -24.62% |
| 2020 | GBX3.98 Million | +67.66% |
| 2019 | GBX2.37 Million | +48.50% |
| 2018 | GBX1.60 Million | -19.87% |
| 2017 | GBX1.99 Million | +12.06% |
| 2016 | GBX1.78 Million | -4.73% |
| 2015 | GBX1.87 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of The Biotech Growth Trust PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.05 Million USD |
| MoneyControl | $4.05 Million USD |
| MarketWatch | $4.05 Million USD |
| marketcap.company | $4.05 Million USD |
| Reuters | $4.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create … Read more